Concepedia

Zana Coulibaly

ZC

Statistics

Publications

6

Citations

1.4K

H-Index

6

Active since

2018

Affiliations

National Cancer Institute(Current)

National Institutes of Health

University of Göttingen

Universitätsmedizin Göttingen

Max Planck Institute for Biophysical Chemistry

Zana Coulibaly is an author at National Cancer Institute specializing in molecular oncology, medicine, and oncology.

Publications per year

2018–2024

6

Publications

6

A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications

George W. Wright, Da Wei Huang, James D. Phelan et al. · Cancer Cell · 2020 · 1.1K citations · Full text

, , +16

Complex electrophysiological remodeling in postinfarction ischemic heart failure

Bence Hegyi, Julie Bossuyt, Leigh G. Griffiths et al. · Proceedings of the National Academy of Sciences · 2018 · 101 citations · Full text

, , +17

SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma

Anne C. Wilke, Carmen Doebele, Alena Zindel et al. · Blood · 2021 · 48 citations · Full text

, , +9

Coupling of SK channels, L-type Ca2+ channels, and ryanodine receptors in cardiomyocytes

Xiaodong Zhang, Zana Coulibaly, Wei Chun Chen et al. · Scientific Reports · 2018 · 47 citations · Full text

, , +17

Response to Bruton’s tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagy

James D. Phelan, Sebastian Scheich, Jaewoo Choi et al. · Cancer Cell · 2024 · 27 citations · Full text

, , +17

1–5 of 6